Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?
From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.
Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.
An examination of how the astronomically deadly and expensive opioid epidemic has generated significant litigation risk for healthcare businesses.
Advice on how the healthcare industry can address the pharmaceutical cost problem.
The next global trend in medicine could be among the many traditional remedies in Indonesia, Vietnam, and China.
A discussion on how mega mergers affect consumers and how consolidation is driving the new future of healthcare.
Health and wellness is shaping consumerism’s future. As potentially industry-shaking partnerships evolve, who’s best positioned to conquer the market?
In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.
2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.